Nautilus Biotechnology (NAUT) vs Vogenx (VOGX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Vogenx is the larger company by market cap ($259.8 million vs $231.6 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | NAUT | VOGX |
|---|---|---|
| Share price | $1.82 | $17.49 |
| Market cap | $231.60M | $259.82M |
| 1-day change | -7.14% | +8.23% |
| YTD return | -6.67% | — |
| 1-year return | +101.77% | — |
| 5-year return | -68.13% | — |
| EPS (TTM) | $-0.45 | $-0.22 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $4.31 | $38.41 |
| 52-week low | $0.82 | $12.95 |
| Distance from 52-week high | -57.77% | -54.46% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +110.44% | +214.47% |
| Average volume | 2.66M | 187.66K |
| Shares outstanding | 127.26M | 14.86M |
| Employees | 127 | 4 |
| Sector | Industrials | Health Care |
| Industry | Biotechnology: Laboratory Analytical Instruments | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- The two companies sit in different sectors: Nautilus Biotechnology in Industrials and Vogenx in Health Care.
About Nautilus Biotechnology
NAUT stock →Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome in the United States. The company develops Nautilus Voyager Platform, which includes an end-to-end solution comprising instruments, reagents, consumables, and software analysis.
Industrials · Biotechnology: Laboratory Analytical Instruments · 127 employees
About Vogenx
VOGX stock →Vogenx, Inc. operates as a clinical-stage drug development company that develops therapeutics for metabolic including post-bariatric hypoglycemia, or PBH, and gastroparesis.
Health Care · Biotechnology: Pharmaceutical Preparations · 4 employees
NAUT vs VOGX FAQ
Which is bigger, Nautilus Biotechnology or Vogenx?
Vogenx (VOGX) is larger, with a market capitalization of $259.82M compared with $231.60M for Nautilus Biotechnology (NAUT).
Are Nautilus Biotechnology and Vogenx in the same industry?
No. Nautilus Biotechnology is in the Industrials sector, while Vogenx is in Health Care.